Quidel Corporation (San Diego, CA) announced it has received an amended Emergency Use Authorization (EUA) from the FDA, allowing Quidel to run its Sofia SARS Antigen FIA, a rapid point-of-care test for COVID-19, on the Sofia Fluorescent Immunoassay Analyzer (Sofia 1), Quidel’s first-generation automated immunoassay instrument. Quidel previously received EUA to run the Sofia … [Read more...]
Sysmex receives approval for safer, faster way to conduct PCR tests for novel coronavirus
Sysmex Corporation (Kobe, Japan) announced it has obtained the first marketing approval in Japan for an in vitro diagnostic medical device, a testing kit for the novel coronavirus (2019-nCoV Fluorescence Detection Real-Time RT-PCR Kit). The company subsequently filed a change request, which was approved June 2, additionally including saliva as a sample type. The company says … [Read more...]
Premier Inc releases statement on CDC Director Testimony before the House Appropriations Committee Regarding Contact Tracing
“Premier agrees with the Centers for Disease Control and Prevention (CDC) Director on the need to have contact tracers across the country to mitigate the spread of COVID-19. Instead of creating a new set of government employees, state and local health departments should invest in hospitals and health systems across the country, many of which have had to furlough or lay off … [Read more...]
Shutdowns prevented 60 million coronavirus infections in the U.S.
Shutdown orders prevented about 60 million novel coronavirus infections in the United States and 285 million in China, according to a research study published Monday that examined how stay-at-home orders and other restrictions limited the spread of the contagion, the Washington Post reported. A separate study from epidemiologists at Imperial College London estimated the … [Read more...]